Expand UTHR Menu
UTHR MENU

UTHR Latest Press Releases

-- April 29, 2026 --

United Therapeutics Corporation Announces Retirement of Professor Raymond Dwek, C.B.E., F.R.S., From Its Board of Directors Business Wire 7:00 AM

-- April 22, 2026 --

United Therapeutics Corporation to Report First Quarter 2026 Financial Results Before Market Open on Wednesday, May 6, 2026 Business Wire 7:00 AM

-- April 20, 2026 --

United Therapeutics Corporation Presents New Data Spanning Pulmonary Hypertension Treatment, Lung Donor Expansion, and Xenotransplantation at ISHLT 2026 Business Wire 6:30 AM

-- April 8, 2026 --

United Therapeutics Receives FDA Regenerative Medicine Advanced Therapy Designation for miroliverELAP for Treatment of Acute Liver Failure Business Wire 7:00 AM

-- March 30, 2026 --

United Therapeutics Corporation Announces TETON-1 Pivotal Study of Tyvaso Meets Primary Endpoint for Treatment of Idiopathic Pulmonary Fibrosis, Exceeding Impressive Treatment Effect Seen in TETON-2 Business Wire 7:00 AM

-- March 11, 2026 --

United Therapeutics Corporation Announces Full Results of TETON-2 Phase 3 Clinical Trial Published in The New England Journal of Medicine Business Wire 6:14 PM

-- March 9, 2026 --

United Therapeutics Corporation Announces $2 Billion Stock Repurchase Authorization and Enters into $1.5 Billion Accelerated Share Repurchase Program Business Wire 7:00 AM

-- March 3, 2026 --

United Therapeutics Corporation to Present at the Leerink Global Healthcare Conference Business Wire 7:00 AM

-- March 2, 2026 --

United Therapeutics Corporation Announces Ralinepag Achieved 55% Reduction in Risk of Clinical Worsening in Pivotal Pulmonary Arterial Hypertension Study, Delivering Exceptional, Highly Statistically Significant Efficacy Business Wire 6:30 AM

-- February 25, 2026 --

United Therapeutics Corporation Reports Fourth Quarter and Full Year 2025 Financial Results Business Wire 6:30 AM

-- February 23, 2026 --

United Therapeutics Corporation to Present at the TD Cowen 46th Annual Health Care Conference Business Wire 7:00 AM

-- February 11, 2026 --

United Therapeutics Corporation to Report Fourth Quarter and Full Year 2025 Financial Results Before the Market Opens on Wednesday, February 25, 2026 Business Wire 7:00 AM

-- January 26, 2026 --

United Therapeutics Announces Positive Results from Phase 1 Study of miroliverELAP in Patients with Acute Liver Failure Business Wire 7:00 AM

-- January 22, 2026 --

United Therapeutics Corporation Announces Appointment of Kevin J. Tracey to its Board of Directors Business Wire 7:00 AM

-- January 7, 2026 --

ReAlta Life Sciences Announces Appointment of Jonathan Rigby to Board of Directors Business Wire 8:00 AM

-- January 5, 2026 --

United Therapeutics Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference Business Wire 7:00 AM
Market Data Delayed 15 Minutes